160 Health International Ltd.HKEX: 2656

Change of executive director and change in composition of nomination committee

· Issued by 160 Health International Ltd. via HKEXnews

Filed with HKEX · Stock code 2656 · · 3 pages · English

Summary by 6ix AI

This filing reports a change in executive director and the composition of the nomination committee at 160 Health International Ltd. Mr. Wang Lifa has resigned as an executive director to focus on personal commitments, effective from a future date. Ms. Wu Shixuan has been appointed as an executive director and a member of the nomination committee, also effective from the same future date. The changes ensure compliance with gender diversity requirements in the nomination committee.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

160 Health International Ltd. on 6ix

Earlier from 160 Health International

Later from 160 Health International

All 160 Health International news releases